


Searching News Database: GGTI-2418
HSMN NewsFeed - 28 Sep 2010
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
HSMN NewsFeed - 4 Mar 2009
FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418
FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418
